|Description||Alvameline, also known as Lu25-109, is a partial M1agonist and M2/M3antagonist that was progressed into clinical studies for the treatment of Alzheimer's disease and Urinary incontinence but was subsequently discontinued.|
|Brife Description||A partial M1 agonist and M2/M3 antagonist|
|Synonyms||5-(2-ethyltetrazol-5-yl)-1-methyl-3,6-dihydro-2H-pyridine; 5-(2-ethyl-2H-tetrazol-5-yl)-1,2,3,6-tetrahydro-1-methylpyridine tartrate; LU 25-109; LU 25-109-T; LU-25-109-T|
|Storage||Store in a cool and dry place (or refer to the Certificate of Analysis).|
|Boiling Point||342.1±52.0 ℃ at 760 Torr|
CDD0102 is a selective M1 agonist which stimulated the secretion of APP from CHO-K1 cells expressing M1 receptors and penetrated into the brain following i.p. a...
MDL 201012 is a selective M3 muscarinic receptor antagonist used as an antimuscarinic agent.
Pyrithioxin, a pyridine thiol derivatives, could be used in the treatment of traumatic brain injury sequelae and some sorts of cerebral infarct patients with He...
Cevimeline is a selective M1 receptor agonist.
PD 102807 is a selective mAChR M4 antagonist with IC50 values of 91, 6559, 3441, 95 and 7412 nM for human M4, M1, M2, M3, and M5 receptors respectively.
DAU 5884 hydrochloride
DAU 5884 hydrochloride is a selective muscarinic M3 receptor antagonist. It inhibits methacholine-dependent effects on cell proliferation and muscle contractili...
VU 0365114 is a selective positive allosteric modulator of M5 muscarinic acetylcholine receptor (mAChR) (EC50 = 2.7 μM for human M5, and >30 μM for M1, M2, M3 a...
Arecaidine propargyl ester tosylate
Arecaidine propargyl ester tosylate is a potent muscarinic receptor agonist. It displays some selectivity for cardiac versus ileal M2 receptors.